{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:43:40Z","timestamp":1791261820188,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1996,4,1]],"date-time":"1996-04-01T00:00:00Z","timestamp":828316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1996,4,1]],"date-time":"1996-04-01T00:00:00Z","timestamp":828316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[1996,4]]},"DOI":"10.1023\/a:1016010524510","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T20:59:24Z","timestamp":1041109164000},"page":"604-610","source":"Crossref","is-referenced-by-count":39,"title":["Immunoliposomes as Enzyme-Carriers (Immuno-Enzymosomes) for Antibody-Directed Enzyme Prodrug Therapy (ADEPT): Optimization of Prodrug Activating Capacity"],"prefix":"10.1007","volume":"13","author":[{"given":"Monique H.","family":"Vingerhoeds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidde J.","family":"Haisma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila O.","family":"Belliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roefke H. P.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan J. A.","family":"Crommelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"306596_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/bc00019a001","volume":"4","author":"P. D. Senter","year":"1993","unstructured":"P. D. Senter, P. M. Wallace, H. P. Svensson, V. M. Vrudhula, D. E. Kerr, I. Hellstr\u00f6m and K. E. Hellstr\u00f6m. Generation of cytotoxic agents by targeted enzymes. Bioconj. Chem.\n4:3\u20139 (1993).","journal-title":"Bioconj. Chem."},{"key":"306596_CR2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/bjc.1994.400","volume":"70","author":"M. P. Deonarain","year":"1994","unstructured":"M. P. Deonarain and A. A. Epenetos. Targeting enzymes for cancer therapy: old enzymes in new roles. Br. J. Cancer\n70:786\u2013794 (1994).","journal-title":"Br. J. Cancer"},{"key":"306596_CR3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/bjc.1988.293","volume":"58","author":"K. D. Bagshawe","year":"1988","unstructured":"K. D. Bagshawe, C. J. Springer, F. Searle, P. Antoniw, S. K. Sharma, R. G. Melton and R. F. Sherwood. A cytotoxic agent can be generated selectively at cancer sites. Br. J. Cancer\n58:700\u2013703 (1988).","journal-title":"Br. J. Cancer"},{"key":"306596_CR4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/bjc.1992.298","volume":"66","author":"H. J. Haisma","year":"1992","unstructured":"H. J. Haisma, E. Boven, M. van Muijen, J. de Jong, W. J. F. van der Vijgh and H. M. Pinedo. A monoclonal antibody-\u03b2-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer. Br. J. Cancer\n66:474\u2013478 (1992).","journal-title":"Br. J. Cancer"},{"key":"306596_CR5","first-page":"17","volume":"1","author":"K. D. Bagshawe","year":"1995","unstructured":"K. D. Bagshawe, S. K. Sharma, C. J. Springer and P. Antoniw. Antibody directed enzyme prodrug therapy: a pilot-scale clinical trial. Tumor Targeting\n1:17\u201329 (1995).","journal-title":"Tumor Targeting"},{"key":"306596_CR6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0014-5793(93)80861-N","volume":"336","author":"M. H. Vingerhoeds","year":"1993","unstructured":"M. H. Vingerhoeds, H. J. Haisma, M. van Muijen, R. B. J. van de Rijt, D. J. A. Crommelin and G. Storm. A new application for liposomes in cancer therapy: immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugs. FEBS Lett.\n336:485\u2013490 (1993).","journal-title":"FEBS Lett."},{"key":"306596_CR7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0005-2736(94)00300-E","volume":"1235","author":"U. K. N\u00e4ssander","year":"1995","unstructured":"U. K. N\u00e4ssander, P. A. Steerenberg, W. H. De Jong, W. O. W. M. van Overveld, C. M. E. te Boekhorst, L. G. Poels, P. H. K. Jap and G. Storm. Design of immunoliposomes directed against human ovarian carcinoma. Biochim. Biophys. Acta\n1235:126\u2013139 (1995).","journal-title":"Biochim. Biophys. Acta"},{"key":"306596_CR8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0003-2697(83)90426-8","volume":"132","author":"R. J. S. Duncan","year":"1983","unstructured":"R. J. S. Duncan, P. D. Weston and R. Wrigglesworth. A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay. Anal. Biochem.\n132:68\u201373 (1983).","journal-title":"Anal. Biochem."},{"key":"306596_CR9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0021-9258(18)84756-1","volume":"66","author":"C. H. Fiske","year":"1925","unstructured":"C. H. Fiske and Y. Subbarow. The colorimetric determination of phosphorus. J. Biol. Chem.\n66:375\u2013400 (1925).","journal-title":"J. Biol. Chem."},{"key":"306596_CR10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0003-2697(84)90782-6","volume":"138","author":"D. Wessel","year":"1984","unstructured":"D. Wessel and U. I. Fl\u00fcgge. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem.\n138:141\u2013143 (1984).","journal-title":"Anal. Biochem."},{"key":"306596_CR11","first-page":"5379","volume":"43","author":"T. C. Hamilton","year":"1983","unstructured":"T. C. Hamilton, R. C. Young, W. M. McKoy, K. R. Grotzinger, J. A. Green, E. W. Chu, J. Whang-Penn, A. M. Rogan, W. R. Green and R. F. Ozols. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res.\n43:5379\u20135389 (1983).","journal-title":"Cancer Res."},{"key":"306596_CR12","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/0040-4039(95)00049-I","volume":"36","author":"R. G. G. Leenders","year":"1995","unstructured":"R. G. G. Leenders, K. A. A. Gerrits, R. Ruijtenbeek, H. W. Scheeren, H. J. Haisma and E. Boven. \u03b2-Glucuronyl carbamate based pro-moieties designed for prodrugs in ADEPT. Tetrahedon Lett.\n36:1701\u20131704 (1995).","journal-title":"Tetrahedon Lett."},{"issue":"1","key":"306596_CR13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0038-1650233","volume":"75","author":"J. L. M. Heeremans","year":"1996","unstructured":"J. L. M. Heeremans, R. Prevost, P. Los, C. Kluft and D. J. A. Crommelin. Fibrin binding glu-plasminogen coated liposomes in vitro. Thromb. Haemostas: 75:1 134\u2013139 (1996).","journal-title":"Thromb. Haemostas"},{"key":"306596_CR14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0163-7258(85)90058-0","volume":"28","author":"J. Connor","year":"1985","unstructured":"J. Connor, S. Sullivan and L. Huang. Monoclonal antibody and liposomes. Pharmacol. Ther.\n28:341\u2013365 (1985).","journal-title":"Pharmacol. Ther."},{"key":"306596_CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02789229","volume":"24","author":"H. J. Haisma","year":"1994","unstructured":"H. J. Haisma, M. van Muijen, H. M. Pinedo, and E. Boven. Comparison of two anthracycline-based prodrugs for activation by a monoclonal antibody-\u03b2-glucuronidase conjugate in the specific treatment of cancer. Cell Biophys.\n24\/25:185\u2013192 (1994).","journal-title":"Cell Biophys."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1016010524510.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1016010524510\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1016010524510.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T06:39:48Z","timestamp":1754030388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1016010524510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996,4]]}},"alternative-id":["306596"],"URL":"https:\/\/doi.org\/10.1023\/a:1016010524510","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,4]]}}}